Authors/Disclosures
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Malgorzata Miller, MD
(Corewell Health)
|
The institution of Dr. Miller has received research support from NIH StrokeNet VERIFY trial. |
|
Denis Brunet, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Lyle E. Weston, MD
|
No disclosure on file |
|
Errol L. Gordon, MD
(Neurology & Stroke)
|
No disclosure on file |
|
Guy A. Rouleau, MD, PhD, FAAN
(Montreal Neurological Institute and Hospital)
|
Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma. |
|
|
No disclosure on file |
|
Neha Dangayach, MD, FAAN
(Icahn School of Medicine At Mount Sinai and Mount Sinai Hospital)
|
Dr. Dangayach has nothing to disclose. |
|
Nicolas Dupre, MD, FAAN
(CHU de Quebec - U Laval)
|
Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation. |
|
|
No disclosure on file |
|
Anil Ramineni, MD
|
Dr. Ramineni has nothing to disclose. |
|
Javaad Ahmad, MD
(Good Samaritan Hospital)
|
No disclosure on file |
|
Stephan A. Mayer, MD
(Henry Ford Hospital)
|
Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ISchemaView. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care. |